Status asthmaticus in children

Current Opinion in Pediatrics

Volumn 19, Issue 3, 2007, Pages 281-287

  Mannix, Rebekah ^a   Bachur, Richard ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Respiratory distress; Review; Status asthmaticus

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; HELIOX; HYDROCORTISONE; IPRATROPIUM BROMIDE; ISOPRENALINE; KETAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; MAGNESIUM; METHYLPREDNISOLONE; METHYLXANTHINE DERIVATIVE; OXYGEN; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; ASTHMATIC STATE; BLOOD GAS ANALYSIS; BRONCHOSPASM; CHILD; CHILDHOOD MORTALITY; CLINICAL FEATURE; DISEASE DURATION; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG INTERMITTENT THERAPY; DRUG SAFETY; ENDOTRACHEAL INTUBATION; HOSPITALIZATION; HUMAN; MEDICAL ASSESSMENT; METERED DOSE INHALER; MORBIDITY; NEBULIZATION; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; STANDARD; STEROID THERAPY; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

CHILD; HUMANS; STATUS ASTHMATICUS;

EID: 34249086298     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3280f77531     Document Type: Review

References (67)

1. Rogers MC, Nichols DG. Textbook of pediatric intensive care. 3rd ed. Baltimore, MD: Williams & Wilkins; 1996.
2. National Center for Health Statistics (US). Summary health statistics for the U.S. population: national health interview survey. Hyattsville, MD: Department of Health & Human Services, Centers for Disease Control and Prevention; 2003. p. v.
3. American Lung Association. Asthma and allergy. http://www.lungusa.org/ site/pp.asp?c=dvLUK9O0E&b=44352. [Accessed 26 February 2007]
4. Robertson CF, Rubinfeld AR, Bowes G. Pediatric asthma deaths in Victoria: the mild are at risk. Pediatr Pulmonol 1992; 13:95-100.
5. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992; 82:59-65.
6. Cropp GJ. Regional differences in prevalence and risks of respiratory diseases in children. Pediatr Pulmonol Suppl 1999; 18:37-40.
7. Chung KF. Noninvasive biomarkers of asthma. Pediatr Pulmonol Suppl 1999; 18:41-44.
8. Frieri M. Asthma concepts in the new millennium: update in asthma pathophysiology. Allergy Asthma Proc 2005; 26:83-88.
9. Gaston B. Managing asthmatic airway inflammation: what is the role of expired nitric oxide measurement? Curr Probl Pediatr 1998; 28:245-252.
10. Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131:599-606.
11. Avital A, Springer C, Bar-Yishay E, Godfrey S. Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50:511-516.
12. Kattan M. Epidemiologic evidence of increased airway reactivity in children with a history of bronchiolitis. J Pediatr 1999; 135 (2 Pt 2):8-13.
13. Pilotto LS, Smith BJ, Nitschke M, et al. Industry, air quality, cigarette smoke and rates of respiratory illness in Port Adelaide. Aust N Z J Public Health 1999; 23:657-660.
14. Platts-Mills TA, Rakes G, Heymann PW. The relevance of allergen exposure to the development of asthma in childhood. J Allergy Clin Immunol 2000; 105 (2 Pt 2):S503-S508.
15. Theodoropoulos DS, Lockey RF, Boyce HW, Bukantz SC. Gastroesophageal reflux and asthma: a review of pathogenesis, diagnosis, and therapy. Allergy 1999; 54:651-661.
16. Vamos M, Kolbe J. Psychological factors in severe chronic asthma. Aust N Z J Psychiatry 1999; 33:538-544.
17. Wahlgren DR, Hovell MF, Meltzer EO, Meltzer SB. Involuntary smoking and asthma. Curr Opin Pulm Med 2000; 6:31-36.
18. Stalcup SA, Mellins RB. Mechanical forces producing pulmonary edema in acute asthma. N Engl J Med 1977; 297:592-596.
19. McFadden ER Jr, Kiser R, DeGroot WJ. Acute bronchial asthma. Relations between clinical and physiologic manifestations. N Engl J Med 1973; 288:221-225.
20. Brenner BE, Abraham E, Simon RR. Position and diaphoresis in acute asthma. Am J Med 1983; 74:1005-1009.
21. Pierson RN Jr, Grieco MH. Pulmonary blood volume in asthma. J Appl Physiol 1972; 32:391-396.
22. Wright RO, Steele DW, Santucci KA, et al. Continuous, noninvasive measurement of pulsus paradoxus in patients with acute asthma. Arch Pediatr Adolesc Med 1996; 150:914-918.
23. Brooks LJ, Cloutier MM, Afshani E. Significance of roentgenographic abnormalities in children hospitalized for asthma. Chest 1982; 82:315-318.
24. Hederos CA, Janson S, Andersson H, Hedlin G. Chest X-ray investigation in newly discovered asthma. Pediatr Allergy Immunol 2004; 15:163-165.
25. Baker JW, Yerger S, Segar WE. Elevated plasma antidiuretic hormone levels in status asthmaticus. Mayo Clin Proc 1976; 51:31-34.
26. Blasi F, Cosentini R, Tarsia P, Allegra L. Potential role of antibiotics in the treatment of asthma. Curr Drug Targets Inflamm Allergy 2004; 3:237-242.
27. Johansson F, Rydberg I, Aberg G, Andersson RG. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Rev Allergy Immunol 1996; 14:57-64.
28. Gawchik SM, Saccar CL, Noonan M, et al. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. J Allergy Clin Immunol 1999; 103:615-621.
29. Nelson HS, Bensch G, Pleskow WW, et al. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102 (6 Pt 1):943-952.
30. Qureshi F, Zaritsky A, Welch C, Meadows T. Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. Ann Emerg Med 2005; 46:29-36.
31. Barry PW, O'Callaghan C. Nebuliser therapy in childhood. Thorax 1997; 52 (Suppl 2):S78-S88.
32. Bisgaard H. Delivery of inhaled medication to children. J Asthma 1997; 34:443-467.
33. Sabato K, Hanson JH. Mechanical ventilation for children with status asthmaticus. Respir Care Clin N Am 2000; 6:171-188.
34. Castro-Rodriguez JA, Rodrigo GJ. beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004; 145:172-177.
35. 2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunol 1988; 81:1101-1109.
36. Montgomery VL, Eid NS. Low-dose beta-agonist continuous nebulization therapy for status asthmaticus in children. J Asthma 1994; 31:201-207.
37. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993; 21:1479-1486.
38. Ackerman AD. Continuous nebulization of inhaled beta-agonists for status asthmaticus in children: a cost-effective therapeutic advance? Crit Care Med 1993; 21:1422-1424.
39. Chiang VW, Burns JP, Rifai N, et al. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr 2000; 137:73-77.
40. Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60:740-746.
41. Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999; 88:835-840.
42. Scarfone RJ, Loiselle JM, Wiley JF, Decker JM. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children. Ann Emerg Med 1995; 26:480-486.
43. Schuh S, Reisman J, Alshehri M, et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000; 343:689-694.
44. Chipps BE, Murphy KR. Assessment and treatment of acute asthma in children. J Pediatr 2006; 147:288-294. An excellent and current review of the clinical literature, including preferred treatment modalities and dosages.
45. Rowe BH, Spooner C, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001; 1:CD002178.
46. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol 1998; 25:1995-2002.
47. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J 1990; 9:729-732.
48. Rosello JC, Pla JC. Sulfato de megnesio en la crisis de asma. Prensa Med Argent 1936; 23:1677-1680.
49. Cheuk DK, Chau TC, Lee SL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child 2005; 90:74-77.
50. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005; 4:CD003898.
51. Mitra A, Bassler D, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over 2 years using inhaled bronchodilators. Cochrane Database Syst Rev 2001; 4:CD001276.
52. Wheeler DS, Jacobs BR, Kenreigh C, Bean J. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care Med 2005; 6:142-147.
53. Carter ER, Webb CR, Moffitt DR. Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial. Chest 1996; 109:1256-1261.
54. Rodrigo G, Pollack C, Rodrigo C, Rowe BH. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2003; 4:CD002884.
55. Gupta VK, Cheifetz IM. Heliox administration in the pediatric intensive care unit: an evidence-based review. Pediatr Crit Care Med 2005; 6:204-211.
56. Kim IK, Phrampus E, Venkataraman S, et al. Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. Pediatrics 2005; 116:1127-1133.
57. Thill PJ, McGuire JK, Baden HP, Green TP. Noninvasive positive-pressure ventilation in children with lower airway obstruction. Pediatr Crit Care Med 2004; 5:337-342.
58. Carroll CL, Schramm CM. Noninvasive positive pressure ventilation for the treatment of status asthmaticus in children. Ann Allergy Asthma Immunol 2006; 96:454-459.
59. Newth CJ, et al. The use of cuffed versus uncuffed endotracheal tubes in pediatric intensive care. J Pediatr 2004; 144:333-337.
60. Werner HA. Status asthmaticus in children: a review. Chest 2001; 119:1913-1929.
61. Stewart TE, Slutsky AS. Occult, occult auto-PEEP in status asthmaticus. Crit Care Med 1996; 24:379-380.
62. Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989; 140:5-9.
63. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg 1993; 76:520-526.
64. Johnston RG, Noseworthy TW, Friesen EG, et al. Isoflurane therapy for status asthmaticus in children and adults. Chest 1990; 97:698-701.
65. Rice M, Hatherill M, Murdoch IA. Rapid response to isoflurane in refractory status asthmaticus. Arch Dis Child 1998; 78:395-396.
66. Nehama J, Pass R, Bechtler-Karsch A, Steinberg C. Continuous ketamine infusion for the treatment of refractory asthma in a mechanically ventilated infant: case report and review of the pediatric literature. Pediatr Emerg Care 1996; 12:294-297.
67. Youssef-Ahmed MZ, Silver P, Nimkoff L, Sagy M. Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med 1996; 22:972-976.